AVNC Advancis Pharmaceutical (MM)

Presentation Will Be Webcast Live and Archived on Company's Web Site GERMANTOWN, Md., Sept. 1 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation (NASDAQ:AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that Dr. Edward M. Rudnic, Advancis president and CEO, will deliver a corporate presentation on Friday, September 8, 2006, at 10:55 a.m. Eastern Time. The presentation will take place as part of the Thomas Weisel Partners Healthcare Conference 2006 at the Four Seasons Hotel Boston in Boston, Massachusetts. Dr. Rudnic's remarks will be available live on the Advancis web site, where they also will be archived for 30 days. To access the presentation, log on to http://www.advancispharm.com/ and click on the Presentations option in the Investor Relations section. Please connect to the web site several minutes prior to the start of the live presentation to ensure adequate time for any software download that may be necessary. About Advancis Pharmaceutical: Advancis Pharmaceutical Corporation (NASDAQ:AVNC) is a pharmaceutical company focused on the development and commercialization of pulsatile drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front- loaded staccato bursts, or "pulses," are killed more efficiently and effectively than those under standard treatment regimens. Based on this finding, Advancis has developed a proprietary, once-a-day pulsatile delivery technology called PULSYS. By examining the resistance patterns of bacteria and applying its delivery technologies, Advancis has the potential to redefine infectious disease therapy and significantly improve drug efficacy, shorten length of therapy, and reduce drug resistance versus currently available antibacterial products. For more on Advancis, please visit http://www.advancispharm.com/. DATASOURCE: Advancis Pharmaceutical Corporation CONTACT: Robert Bannon, Sr. Director, Investor Relations of Advancis Pharmaceutical Corporation, +1-301-944-6710, or Web site: http://www.advancispharm.com/

Copyright